Deep Track Capital’s Nektar Therapeutics NKTR Stock Holding History

Deep Track Capital’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.9M	Buy	+300,000	New	+$22M	0.3%	57
2025 Q1	–	Sell	-131,733	Closed	-$1.84M	–	74
2024 Q4	$1.84M	Sell	131,733 -929,777	-88%	-$16.4M	0.07%	62
2024 Q3	$20.7M	Sell	1,061,510 -130,190	-11%	-$2.48M	0.66%	41
2024 Q2	$22.2M	Sell	1,191,700 -34,967	-3%	-$737K	0.66%	41
2024 Q1	$17.2M	Hold	1,226,667	–	–	0.49%	46
2023 Q4	$10.4M	Hold	1,226,667	–	–	0.35%	51
2023 Q3	$11M	Buy	1,226,667 +28,436	+2%	+$274K	0.42%	46
2023 Q2	$10.3M	Buy	1,198,231 +1,082,014	+931%	+$11.5M	0.48%	41
2023 Q1	$1.23M	Buy	+116,217	New	+$3.52M	0.05%	57

Other funds holding NKTR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deep Track Capital's NKTR Position: Q2 2026 in Review

Deep Track Capital opened a new position in Nektar Therapeutics (NKTR) in Q2 2026: 300,000 shares worth $20.9M. The stake represents 0.3% of the portfolio and ranks #57 among its holdings. This is a return to the name: Deep Track Capital previously reported a position in NKTR as recently as Q4 2024.

Deep Track Capital first reported a position in NKTR in Q1 2023 and has held it in 9 quarters since. The position peaked at $22.2M in Q2 2024. 240 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

Deep Track Capital held 300,000 shares of Nektar Therapeutics worth $20.9M as of Q2 2026.
Nektar Therapeutics was a new Deep Track Capital position in Q2 2026.
Nektar Therapeutics made up 0.3% of Deep Track Capital's portfolio in Q2 2026, its #57 holding.
Deep Track Capital first reported a position in Nektar Therapeutics in Q1 2023 and has held it in 9 quarters since.
Deep Track Capital's Nektar Therapeutics position peaked at $22.2M in Q2 2024.
240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.